Top 10 Life Science Startup Investors in Norway in July 2025
A list of 10 angel investors and VC (Venture Capital) funds that invest in Life science startups based in Norway. We rank investors based on the number of investments they made in Life science companies from Norway. We update this investor list every month.Top 10 Life Science Startup Investors in Norway in July 2025
Investor | Life Science Norway investments |
---|---|
Investinor | 2 |
The Index Project | 1 |
Canica | 1 |
Nordic Impact | 1 |
Project Sandwater | 1 |
Birk Venture | 1 |
Bakken & Baeck | 1 |
Hadean Ventures | 1 |
SINTEF Venture AS | 1 |
World Wildlife Fund | 1 |
Investinor invests in Norwegian based, high potential companies that are internationally oriented and in the phases ranging from early growth to expansion. The company has BNOK 4.2 ($500 m) under management and focus on companies within the internet, software, semiconductors, energy, cleantech, marine and life sciences sectors.
Show more
Investment focus
- Software, Biotechnology, Manufacturing
- Funding Round, Seed, Series A
- Norway, United States, Switzerland
Portfolio highlights
- Calluna Pharma — Join Calluna Pharma to transform therapeutics for inflammatory and fibrotic diseases. With a robust pipeline, seasoned leadership, and strategic alliances, we can revolutionize patient care.
- Ignite — A powerful & easy spend management tool to accelerate your procurement success by bringing clarity, clean data & sophisticated analytics to your fingertips
- Tribune Therapeutics — Tribune Therapeutics is a preclinical biopharmaceutical company building a promising pipeline of novel medicines to treat patients with a wide range of fibrotic diseases. It was founded in 2020 with funding from HealthCap and Novo Seeds.
Design to improve life is about solving real problems, small and large, simple and complex, systemic and emerging and is a life-long pursuit. The Index Project is a call to action. Are you in?
Show more
Investment focus
- Artificial Intelligence, Chemical, SaaS
- Seed, Series A, Series B
- United States, Denmark, Chile
Canica is one of the largest privately owned investment companies in Norway. Our operations are focused on active, long-term ownership, primarily within sectors covering retail, fast moving consumer goods and real estate. Canica can offer core expertise within the fields of business development and finance, as well as capital and network in orderto create value and employment in a long-term perspective.
Show more
Investment focus
- Beauty, Medical, Biotechnology
- Private Equity, Series A, Series D
- Norway, Denmark, Switzerland
Portfolio highlights
- Cytovation — Cytovation AS is a privately-held biotech company, specialising in dermatological diseases, based in Bergen, Norway.
- Porterbuddy — They are the gang that delivers to your door the same day you order in the online store.Porterbuddy' is a logistics platform that provides efficient and customer-centric, last-mile delivery of products.
- Galecto — Galecto develops small molecules for the treatment of severe diseases, including fibrosis and cancer. The company lead product candidate, GB0139, is an inhaled inhibitor of galectin-3. GB0139 is being developed for the treatment of severe fibrotic lung diseases such as idiopathic pulmonary fibrosis, or IPF, in which there is high unmet medicalneed. Galecto was founded in 2011, builds on more than 10 years of research centering on the role of galectin-3 and LOXL-2, and the use of modulators of these proteins to treat fibrosis-related diseases and cancer. Combined with a strong patent estate, these assets give Galecto a unique therapeutic platform.
Nordic Impact invests in, supports, and builds businesses and funds based around technology. The company's goal is to make impact investing mainstream and mobilize all business and capital towards solving the big problems in the world while making great financial returns.
Show more
Investment focus
- Chemical, Life Science, Visual Search
- Seed
- Norway
Portfolio highlights
- Iris.ai — AI for scientific text understanding - Smart search, reading list analysis, auto-generated summaries, data extraction, chatbot with references.
Project Sandwater is a fresh take on venture investments within the Nordics and beyond.
Show more
Investment focus
- Medical, Consulting, Life Science
- Series A
- Norway, The Netherlands
Portfolio highlights
- Delft IMP — Delft IMP (Intensified Materials Production) commercializes nanostructuring of particles using atomic and molecular layer deposition (ALD and MLD), based on the patented and publicized IP and know-how developed within the Product & Process Engineering (PPE) group at Delft University of Technology. Following various feasibility projects betweenindustry and university, Delft IMP was initiated end 2014 to truly commercialize the technology.
- Cytovation — Cytovation AS is a privately-held biotech company, specialising in dermatological diseases, based in Bergen, Norway.
Birk Venture is a Scandinavian venture company exclusively focusing on the life science industry.
Show more
Investment focus
- Biotechnology, Medical, Health Care
- Seed, Series A, Funding Round
- Norway, United Kingdom
Portfolio highlights
- APIM Therapeutics — APIM Therapeutics is based on an original discovery by Prof. Marit Otterlei and co-inventors at the Department of Cancer Research and Molecular Medicine at NTNU (Trondheim, Norway). The company is currently developing proprietary peptide drugs targeting PCNA (Proliferating Cell Nuclear Antigen), a key DNA repair protein regulating cellularresponses to DNA damage and stress.
- Zelluna Immunotherapy — Zelluna Immunotherapy AS is a privately owned biopharmaceutical company focused on the development of TCR based immunotherapies.
- Accession Therapeutics — Accession Therapeutics’ elegant Trocept platform has potential to treat some of the most intractable and widespread forms of cancer. Based in Oxford, UK, it is developing a pipeline of products to the early clinical trial stage. Led by Bent Jakobsen, PhD FMedSci, a pioneer of T cell receptor therapy for cancer, the team is highly experienced intaking immuno-oncology products to the clinic. Accession Therapeutics’ Trocept technology is based on over a decade’s work and has generated exceptional preclinical data.Accession Therapeutics’ proprietary technology incorporates cancer-tropic viruses, the first time that viruses have been genetically modified to exclusively target cancer cells. As non-cancerous cells are not targeted by Trocept, systemic toxicity is eliminated meaning the drugs can be delivered intravenously and traffic to the tumour. Trocept’s highly potent and local activity gives it potential in some of the hardest to treat and most widespread forms of cancer. This includes breast, cervical, colorectal, gastric, head and neck, lung, oral, ovarian and pancreatic cancer.
Since 2011, we have built products with some of the most ambitious companies out there. From defining future homes with IKEA to building decentralised platforms with Coinbase.
Show more
Investment focus
- Chemical, Software, Life Science
- Seed, Angel
- Norway
Portfolio highlights
- Versor — Versor develops software necessary for true autonomous drone flight both indoors and outdoors, enabling complete automation of industrial drone operations. They believe this level of automation requires superior localization, which is particularly difficult to achieve indoors and in GPS-denied areas. By removing the need for pilots, entire fleetsof drones may be supervised remotely, enabling true scalability of drone operations across various applications.
- Iris.ai — AI for scientific text understanding - Smart search, reading list analysis, auto-generated summaries, data extraction, chatbot with references.
Hadean Ventures is a life science fund manager that invests in life science companies across europe with a particular focus on the nordic region.
The funds are backed by leading private and institutional investors.
Hadean Ventures has offices in oslo and stockholm and collaborates with world-class academic institutions and start-up hubs across theregion
Show more
Investment focus
- Biotechnology, Health Care, Pharmaceutical
- Series A, Funding Round, Series B
- Sweden, Norway, Austria
Portfolio highlights
- SciRhom — SciRhom GmbH is a biotech company that translates science into the preclinical and early clinical development of novel biopharmaceuticals for the treatment of life-threatening autoimmune diseases. Based on longstanding academic research and a well-established network of experts, SciRhom was founded in 2016 through a collaboration between academicand industry scientists with profound experience in antibody development.
- Gesynta Pharma — Founded in 2017, Gesynta Pharma bases its R&D on research from the Karolinska Institutet. The most advanced drug candidate, GS-248, reduces inflammation and increases blood flow in the microvasculature, thereby having the potential to provide improved treatments for several serious diseases. In an ongoing clinical proof-of-concept study,GS-248 is being evaluated for its capacity to normalize vascular blood flow and reduce pain in patients with the autoimmune disease systemic sclerosis. Positive results from this study may lead to a rapid broadening of the development program towards additional indications, for example cardiovascular diseases and rheumatic diseases other than systemic sclerosis. Major shareholders include Industrifonden, Linc, Hadean Ventures, and a number of successful life science entrepreneurs. For more information, please visit www.gesynta.se
- Alex Therapeutics — The Alex DTx Platform enables partners within pharma and health care to effectively and reliably launch new DTx treatments by leveraging existing insights, modules, processes and data.
We commercialize technology created by SINTEF's research environments
Show more
Investment focus
- Manufacturing, Software, Energy
- Seed, Funding Round, Pre-Seed
- Norway, United States, United Kingdom
Portfolio highlights
- Nomono — Nomono offers an all-in-one portable podcast kit, the Sound Capsule, designed for effortless recording and professional-quality audio. Simply press record to capture studio-quality sound anywhere, with no setup required. Enhance and edit your podcasts seamlessly with Nomono Cloud's AI-powered audio processing. Ideal for podcasters and broadcast journalists seeking a streamlined workflow and exceptional sound quality.
- Hystar — Hystar develops polymer electrolyte membrane electrolyzers designed for large-scale green hydrogen production. Founded in 2020, Hystar's technology uses a unique cell design and process architecture that provides the ability to reduce electricity consumption and increase hydrogen output, enabling professionals to tackle various criticalenergy challenges and having the potential to reduce greenhouse gas emissions.
- Hydrogen Mem-Tech — Hydrogen Mem-Tech aim is to make the green shift happen through our state-of-the-art hydrogen separation technology with carbon capture.
World Wildlife Fund - The leading organization in wildlife conservation and endangered species. Learn how you can help WWF make a difference.
Show more
Investment focus
- Seafood, Food Processing, Farming
- Seed, Series A, Funding Round
- Norway, Faroe Islands, United Kingdom
Portfolio highlights
- OCEANIUM — OCEANIUM is a world-leading developer of innovative, functional seaweed ingredients to catalyse the seaweed industry for People Health and Ocean Health.
- Ocean Rainforest — Ocean Rainforest offer a collection of premium fully-traceable seaweed products, mostly for food and cosmetic producers.
- Seaweed Solutions — Seaweed Solutions AS is one of Europe's largest seaweed farmers based in Norway. Our experience in seaweed farming dates back to 1978.
Investors by industry
Consumer
Proptech
Impact
Climate
Gaming
Biotech
FinTech
Marketplace
Community
Health Care
Hardware
Energy
EdTech
Artificial intelligence
Sustainability
Venture Capital
Real Estate
Photography
Clean Energy
Education
Google
B2B
Financial Services
Big Data
Payments
Finance
Organic Food
Food and Beverage
Web3
Infrastructure
Retail
Beauty
Music
Publishing
Video Games
Hospitality
Platforms
Biotechnology
Cannabis
Mobile Advertising
Art
Travel
Fitness
Recruiting
Crowdfunding
Social
Medical Device
Wellness
Automotive
Wine And Spirits
CleanTech
Mobile Apps
Transportation
InsurTech
Franchise
Enterprise
Mobile
LGBT
Local
Digital Media
Legal
Android
eSports
Enterprise Software
Fashion
Oil and Gas
Sports
Manufacturing
Life Science
Theatre
Film
Email
Medical
Social Network
Social Media
Non Profit
Internet
Construction
Renewable Energy
SaaS
Sporting Goods
Celebrity
Restaurants
Social Impact
Software
Cryptocurrency
Machine Learning
Facebook
Agriculture (agtech)
Media (entertainment)
Blockchain
Investors by country
Canada
Germany
United Kingdom
Ireland
South Korea
India
Australia
New Zealand
United States
Middle East
Brazil
LATAM
Qatar
Indonesia
Asia
Europe
Spain
South Africa
Singapore
Armenia
Saudi Arabia
Sri Lanka
China
Africa
Oceania
Japan
Vietnam
Belarus
Chile
Belgium
Hong Kong
Finland
Ghana
Georgia
Ethiopia
Gibraltar
Faroe Islands
Denmark
Egypt
Estonia
Costa Rica
Hungary
Greece
Barbados
Croatia
Belize
Bahrain
Czech Republic
Kuwait
Malta
Morocco
Algeria
Nicaragua
Ecuador
Mali
Lithuania
Bulgaria
Peru
Lebanon
Bermuda
France
Jersey
Norway
Poland
Myanmar
Mauritius
Senegal
Liberia
Mexico
Malaysia
Sierra Leone
Tunisia
Liechtenstein
Togo
Serbia
Philippines
Turkey
Italy
San Marino
Thailand
Israel
Uzbekistan
Taiwan
Panama
Sweden
Dominican Republic
Tanzania
Nigeria
Iraq
Slovenia
Azerbaijan
Bahamas
Iceland
El Salvador
Namibia
United Arab Emirates
Portugal
Jamaica
Honduras
Bolivia
Isle of Man
Tajikistan
Ukraine
Luxembourg
Albania
Pakistan
Puerto Rico
Uganda
Grenada
Jordan
Bangladesh
Venezuela
Argentina
Romania
Uruguay
Zambia
Zimbabwe
Rwanda
Russian Federation
Kazakhstan
Kenya
Cayman Islands
Cambodia
Latvia
Cyprus
Oman
Cameroon
Austria
Switzerland
Seychelles
Colombia
Guatemala
Marshall Islands
Investors in Norway by industry
Clean Energy
Transportation
Financial Services
Cryptocurrency
Big Data
Payments
Medical
Social Network
Social Media
Medical Device
Internet
Manufacturing
Blockchain
Software
Construction
Enterprise Software
Sports
CleanTech
Travel
FinTech
EdTech
Biotechnology
Consumer
Health Care
Climate
Mobile
Sustainability
Energy
Proptech
Impact
SaaS
Artificial intelligence
Marketplace
Hardware
Community
Gaming
Retail
Fashion
Social
Web3
B2B
Life Science
Publishing
Oil and Gas
Education
Renewable Energy
Music
Enterprise
Biotech
Video Games
Finance
Food and Beverage
Real Estate
Media (entertainment)
Agriculture (agtech)
Digital Media
Machine Learning